茵芪三黄解毒汤联合常规西医治疗慢性乙型肝炎肝胆湿热证患者的疗效观察

Effect observation of Yinqi Sanhuang Jiedu Decoction combined with conventional western medicine in treatment of patients with chronic hepatitis B differentiated as syndrome of dampness and heat in liver and gallbladder

  • 摘要:
      目的  观察茵芪三黄解毒汤联合常规西医治疗慢性乙型肝炎肝胆湿热证患者的临床疗效。
      方法  将94例慢性乙型肝炎肝胆湿热证患者随机分为2组,每组47例。对照组采取常规西医治疗,观察组在此基础上加服茵芪三黄解毒汤。比较2组临床疗效、中医证候评分、细胞因子、肝功能指标及不良反应。
      结果  观察组总有效率为93.61%,高于对照组的76.59%,差异有统计学意义(P < 0.05)。治疗后,2组主症得分、次症得分、肿瘤坏死因子-α、白细胞介素-4、总胆红素、谷氨酸-丙酮酸转氨酶及天门冬氨酸转氨酶水平均下降,且观察组低于对照组,差异有统计学意义(P < 0.05)。治疗后,2组白细胞介素-2水平均升高,且观察组高于对照组,差异有统计学意义(P < 0.05)。对照组不良反应发生率为6.38%,观察组为8.51%,差异无统计学意义(P>0.05)。
      结论  茵芪三黄解毒汤联合常规西医治疗慢性乙型肝炎肝胆湿热证患者的疗效显著,可改善临床症状,其作用机制可能与缓解炎症反应、保护肝细胞有关。

     

    Abstract:
      Objective  To observe the clinical effect of Yinqi Sanhuang Jiedu Decoction combined with conventional western medicine in treatment of patients with chronic hepatitis B differentiated as syndrome of dampness and heat in liver and gallbladder.
      Methods  Totally 94 patients with chronic hepatitis B differentiated as syndrome of dampness and heat in liver and gallbladder were randomly divided into two groups, with 47 cases in each group. The control group was treated with conventional western medicine, and the observation group was treated with Yinqi Sanhuang Jiedu Decoction on this basis of the control group. The clinical efficacy, scores of traditional Chinese medicine (TCM) syndromes, cytokines, liver function indexes and adverse reactions were compared between the two groups.
      Results  The total effective rate of the observation group was 93.61%, which was significantly higher than 76.59% of the control group (P < 0.05). After treatment, the scores of the primary and secondary syndromes, tumor necrosis factor-α, interleukin-4, total bilirubin, alanine aminotransferase and aspartate aminotransferase levels in both groups decreased significantly, and these indexes in the observation group were significantly lower than those in the control group (P < 0.05). After treatment, the level of interleukin-2 in bothgroups significantly increased, and the level of interleukin-2 in the observation group was significantly higher than that in the control group (P < 0.05). The incidence of adverse reactions was 6.38% in the control group and 8.51% in the observation group, and there was no significant difference between two groups (P>0.05).
      Conclusion  Yinqi Sanhuang Jiedu Decoction combined with conventional western medicine is effective in treatment of patients with chronic hepatitis B differentiated as syndrome of dampness and heat in liver and gallbladder, which can improve the clinical symptoms, and the mechanism may be related to relieving inflammatory reaction and protecting hepatocytes.

     

/

返回文章
返回